FemTech Startups

Neqabty is an Egyptian company that builds a mobile application for members of professional syndicates. Through the app, members can pay membership and service fees, handle medical costs such as prescriptions, renewals, and treatment charges, and book syndicate events and trips.

1 investor

Nestmedic develops Pregnabit, a mobile CTG (cardiotocography) device for remote fetal and maternal monitoring during pregnancy. The company serves expectant mothers and healthcare providers in the field of telemedicine and prenatal care.

1 investor

Neuemoon is a health platform built to support young girls and women in understanding menstrual health and accessing information about conditions like endometriosis and fibroids. The company aims to help women recognize abnormal symptoms and connect with appropriate medical care earlier than traditional pathways.

1 investor

Newmi is a women's health platform in India that combines virtual consultations, in-clinic visits, diagnostics, pharmacy and preventive care across life stages from puberty to menopause. It also offers women-focused outpatient care as a corporate benefit for employers, insurers, and brokers.

1 investor

A biotechnology company developing patent-pending technology to combat antibiotic resistance by targeting bacterial resistance mechanisms and restoring the effectiveness of existing antibiotics.

1 investor

NextGen Jane runs a longitudinal molecular study of women's menstruation, using an at-home organic cotton tampon collection kit that members mail in to derive genomic insights from uterine samples. The company aims to improve diagnostics and treatment for gynecological conditions such as endometriosis and other menstrual and reproductive health issues.

1 investor

nonat Inc. develops MIKAZUKI, a smartphone app that captures raw biometric data, and conducts clinical research aimed at newborns/small lives and their families. The company operates as a licensed medical device manufacturer and seller in Japan.

1 investor

Nooshee is a consumer product company focused on early parenthood, starting with a redesigned breast pump. It targets new parents.

1 investor

Nopausa provides a menopause support program combining a free self-assessment (MenoCheck) with personalized plans and care from licensed professionals across gynecology, endocrinology, nutrition, mental health, and movement. It also sells a corporate offering to employers, including employee program access, leadership training, anonymized reporting, and internal menopause policy design to help retain senior female talent.

1 investor

Notify develops pharmaceutical treatments for women with diminished ovarian reserves by targeting dormant follicle activation through NRF2 pathway modulation. The company's approach addresses early-stage egg development independent of hormonal processes, offering a potential solution for women who do not benefit from existing fertility treatments.

1 investor

Nova IVF is a fertility clinic offering comprehensive reproductive endocrinology and infertility services, including IVF, fertility preservation, and reproductive surgery, with personalized treatment plans for patients. It is based in Mountain View, California.

1 investor

Nua is a direct-to-consumer women's personal care brand offering menstrual products such as sanitary pads, along with related digital tools like a period tracker. It serves women managing menstrual and personal wellness needs.

1 investor

Nuevométodo is an international digital health services provider that partners with insurance companies to integrate personalized wellness and mental health offerings into their policies. The company serves insurance carriers across Latin America, Spain, Portugal, and Puerto Rico.

1 investor

Nuvo provides remote monitoring technology for maternity care, aimed at improving outcomes and lowering costs. Its platform supports maternal health initiatives for healthcare providers.

1 investor

Nyssa designs "wear therapy" products for women, including postpartum recovery underwear and period care solutions that hold ice or heat therapy for healing and pain relief. The company also offers educational content developed with OB-GYNs and doulas covering women's health from puberty to postpartum to menopause.

1 investor

Nyungu manufactures sustainable, plant-based menstrual products using pineapple leaves and corn husk fibers for women and girls, with a social mission to donate products to those who cannot afford them. The company operates in Kenya with a focus on climate-positive production and menstrual health equity.

1 investor

O Positiv makes science-backed supplements for women's hormonal and vaginal health, including PMS gummy vitamins (FLO), menopause relief gummies (MENO), and a vaginal probiotic (URO). The direct-to-consumer brand focuses on women's health needs across life stages, from menstruation to menopause.

1 investor

Obi Health operates a network that extends the reach of reproductive endocrinologists, letting fertility patients receive most monitoring and care locally through partner OBGYN clinics while only visiting distant fertility clinics as needed. It serves fertility clinics, OBGYN clinics, and patients across the US via an app that coordinates care between local providers and fertility clinics.

1 investor

Oiselle is a running apparel brand that designs and sells athletic gear for women. The company operates Volée, a membership community for female runners that provides shipping discounts, early product access, digital community features, and local meetup opportunities.

1 investor

Okionu provides postpartum doula training, mentorship, and business development for birth professionals, along with personalized postpartum planning services for families. It focuses on maternal and postpartum health through culturally centered education, advocacy, and storytelling.

1 investor

Okkanti operates a platform connecting pregnant and parenting people with vetted doulas, midwives, lactation specialists, and postpartum care providers. The marketplace also enables doctors to refer care professionals without bias and supports the sustainability of independent maternal and postpartum care workers.

1 investor

Opal Therapeutics develops organoid models and therapies centered on female biology to improve drug discovery outcomes in women's health. The company addresses the underserved space of female-specific drug development by building human-relevant models that better capture female biological characteristics.

1 investor

Organic Mondays provides menstrual health care with wall-mounted dispensers and organic, plastic-free period products supplied in bulk to businesses, schools, and sports venues. It positions the offering around sustainability and helping organizations meet ESG targets.

1 investor

Origyn Medical develops minimally invasive gynecological medical devices, including hysteroscopy instruments, cervical health products, women's rehabilitation devices, and gynecological diagnostic tools such as a single-use electronic endoscope. The company serves clinicians and hospitals in the women's health field, with operations in Hangzhou and Hunan, China.

1 investor